Psagot Value Holdings’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
WBG
FMP
BCM
HCIA
FCBT
Psagot Value Holdings's XPH Position: Q1 2020 in Review
Psagot Value Holdings sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2020, closing a stake of 1,147 shares — an estimated $52K sold.
Psagot Value Holdings first reported a position in XPH in Q3 2015 and held it in 18 quarters. The position peaked at $23.2M in Q4 2015. 66 funds tracked by Wall St. Rank hold XPH as of Q1 2020.
- Psagot Value Holdings reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
- Psagot Value Holdings sold 1,147 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2020, an estimated $52K.
- Psagot Value Holdings first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2015 and held it in 18 quarters.
- Psagot Value Holdings's State Street SPDR S&P Pharmaceuticals ETF position peaked at $23.2M in Q4 2015.
- 66 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2020.
Based on Psagot Value Holdings's 13F filing for Q1 2020, filed 12 May 2020.